9 reports

KEY FINDINGS The North America neurorehabilitation device market is registered to grow with a CAGR of 14.35%, over the forecast years of 2021 to 2028. The growing geriatric populace, the investments made for preventing and diagnosing neurogenerative ailments, the increased incidence of neurological conditions, and the rising...

  • Dementia
  • Neurological Disorder
  • Therapy
  • Canada
  • North America
  • Dementia Incidence

KEY FINDINGS The North America Alzheimer’s disease therapeutics & diagnostics market is predicted to increase with a 6.46% CAGR between the estimated years 2022 and 2030. Due to anticipated sales growth and the prospect of new therapies gaining market approval, the market is surging in the region. MARKET...

  • Dementia
  • Diagnostics
  • North America
  • Canada
  • Dementia Incidence

KEY FINDINGS The North America digital genome market is evaluated to project a CAGR of 9.60%, during the forecast years of 2021 to 2028. The high prevalence of infectious diseases, dementia, Alzheimer’s disease, and cancer, the growing incidence of monogenic conditions, and the rising adoption of advanced techniques by...

  • Infectious Disease
  • Dementia
  • Cardiovascular Disease
  • Bioinformatics
  • Hospital
  • North America
  • Canada

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Frontotemporal Lobe Dementia in 19 Major Markets Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised by degeneration and atrophy of the frontal and anterior temporal lobes. It is the second most common neurodegenerative...

  • Dementia
  • Epidemiology
  • South Korea
  • Japan
  • Italy
  • India
  • Brazil
  • United Kingdom
  • Germany
  • China
  • Turkey
  • United States
  • Spain
  • Canada
  • France
  • Australia
  • Poland
  • Russia
  • Mexico
  • Argentina
  • Netherlands
  • Dementia Prevalence
  • Life Expectancy

Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2029 Summary Amyotrophic Lateral Sclerosis (ALS) is a motor neuron degenerative disease which affects both upper motor neurons (UMN) and lower motor neurons (LMN).It is a progressive disease, with patients becoming increasingly...

  • Dementia
  • United States
  • Canada
  • Japan
  • World
  • Drug Approval
  • Biologics Penetration Rate

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Mild Cognitive Impairment in 14 Major Markets Mild cognitive impairment (MCI) is a condition in which a person has problems with memory, language, executive function and visuospatial skills that are noticeable to others and can be observed in neuropsychological...

  • Dementia
  • Italy
  • Japan
  • United States
  • Germany
  • China
  • United Kingdom
  • India
  • Brazil
  • Mexico
  • Spain
  • Russia
  • Canada
  • France
  • Australia
  • Dementia Prevalence
  • Diagnostic Imaging Density

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Vascular Dementia in 13 Major Markets Vascular Dementia (VaD) is the second most common form of dementia after Alzheimer disease. It is also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), and is caused by issues with blood supply...

  • Dementia
  • South Korea
  • United States
  • Japan
  • Brazil
  • India
  • Canada
  • China
  • United Kingdom
  • Spain
  • Germany
  • Italy
  • France
  • Dementia Prevalence
  • Dementia Incidence

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Alzheimer’s disease in 12 Major Markets Alzheimer’s disease (AD) is a progressive, irreversible neurodegenerative disorder. It is the leading cause of dementia. Alzheimer’s is associated with the increase of beta amyloid and tau proteins in the brains of affected patients....

  • Dementia
  • India
  • United States
  • Japan
  • Brazil
  • China
  • United Kingdom
  • Spain
  • Germany
  • Canada
  • Russia
  • Italy
  • France
  • Dementia Prevalence
  • Dementia Incidence

Summary Oxford Biodynamics Ltd (Oxford Bio) is a health-care service company that discovers and develops biomarker discovery platform. The company’s biomarker discovery platform is used for the detection of aberrant gene expression. It concentrates on research in detection, monitoring and prognosis of major diseases associated...

  • Diagnostics
  • Dementia
  • World
  • Asia
  • India
  • Canada
  • Diabetes Prevalence
  • Medical Devices Sales